Hillsdale Investment Management Inc. Rx Sight, Inc. Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$40.78 - $57.04 $815 - $1,140	-20 Reduced 0.03%	70,010 $3.46 Million
Q2 2024 Aug 13, 2024	SELL	$50.42 - $64.29 $307,562 - $392,169	-6,100 Reduced 8.01%	70,030 $4.21 Million
Q1 2024 May 10, 2024	BUY	$35.51 - $57.92 $2.7 Million - $4.4 Million	75,980 Added 50653.33%	76,130 $3.93 Million
Q4 2023 Feb 09, 2024	BUY	$20.91 - $40.9 $3,136 - $6,135	150 New	150 $6,000

185

35.2M

53.1K

62.6K

Ticker RXST
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 27,638,900
Market Cap $203M
Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.